Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1966 3
1974 2
1975 2
1976 2
1977 5
1978 3
1979 1
1980 4
1982 2
1983 4
1984 7
1985 12
1986 3
1987 11
1988 2
1989 11
1990 6
1991 10
1992 7
1993 19
1994 16
1995 17
1996 16
1997 17
1998 30
1999 32
2000 44
2001 51
2002 51
2003 71
2004 93
2005 120
2006 115
2007 125
2008 133
2009 187
2010 204
2011 214
2012 212
2013 218
2014 222
2015 272
2016 253
2017 217
2018 222
2019 247
2020 250
2021 180
Text availability
Article attribute
Article type
Publication date

Search Results

3,513 results
Results by year
Filters applied: . Clear all
Page 1
Targeting hydrogen sulphide signaling in breast cancer.
Youness RA, Gad AZ, Sanber K, Ahn YJ, Lee GJ, Khallaf E, Hafez HM, Motaal AA, Ahmed N, Gad MZ. Youness RA, et al. Among authors: ahn yj. J Adv Res. 2020 Jul 16;27:177-190. doi: 10.1016/j.jare.2020.07.006. eCollection 2021 Jan. J Adv Res. 2020. PMID: 33318876 Free PMC article. Review.
A prospective, multicentre, randomised, open-label trial to compare the efficacy and safety of clopidogrel versus ticagrelor in stabilised patients with acute myocardial infarction after percutaneous coronary intervention: rationale and design of the TALOS-AMI trial.
Park MW, Kim CJ, Kim MC, Choo EH, Hwang BH, Park CS, Kim HY, Yoo KD, Jeon DS, Jeong MH, Seung KB, Ahn Y, Chang K. Park MW, et al. Among authors: ahn y. EuroIntervention. 2021 Feb 19;16(14):1170-1176. doi: 10.4244/EIJ-D-20-00187. EuroIntervention. 2021. PMID: 32718912 Free article. Clinical Trial.
Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants.
Smith BD, Kaufman MD, Lu WP, Gupta A, Leary CB, Wise SC, Rutkoski TJ, Ahn YM, Al-Ani G, Bulfer SL, Caldwell TM, Chun L, Ensinger CL, Hood MM, McKinley A, Patt WC, Ruiz-Soto R, Su Y, Telikepalli H, Town A, Turner BA, Vogeti L, Vogeti S, Yates K, Janku F, Abdul Razak AR, Rosen O, Heinrich MC, Flynn DL. Smith BD, et al. Among authors: ahn ym. Cancer Cell. 2019 May 13;35(5):738-751.e9. doi: 10.1016/j.ccell.2019.04.006. Cancer Cell. 2019. PMID: 31085175 Free article.
The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 2. Management of H1-Antihistamine-Refractory Chronic Urticaria.
Choi JH, Lee DH, Song WJ, Choi M, Kwon JW, Kim GW, Kim MH, Kim MA, Kim MH, Kim BK, Kim S, Kim JS, Kim JE, Kim JY, Kim JH, Kim HJ, Kim HO, Kim HB, Roh JY, Park KH, Park KY, Park HK, Park H, Bae JM, Byun JY, Song DJ, Ahn YM, Lee SE, Lee YB, Lee JS, Lee JH, Lim KH, Youn SW, Chang YS, Jeon YH, Jeon J, Jue MS, Choi SH, Hur GY, Lim DH, Ye YM, Park YM. Choi JH, et al. Among authors: ahn ym. Allergy Asthma Immunol Res. 2020 Sep;12(5):750-770. doi: 10.4168/aair.2020.12.5.750. Allergy Asthma Immunol Res. 2020. PMID: 32638557 Free PMC article. Review.
Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer.
Lin KH, Rutter JC, Xie A, Pardieu B, Winn ET, Bello RD, Forget A, Itzykson R, Ahn YR, Dai Z, Sobhan RT, Anderson GR, Singleton KR, Decker AE, Winter PS, Locasale JW, Crawford L, Puissant A, Wood KC. Lin KH, et al. Among authors: ahn yr. Nat Genet. 2020 Apr;52(4):408-417. doi: 10.1038/s41588-020-0590-9. Epub 2020 Mar 16. Nat Genet. 2020. PMID: 32203462 Free PMC article.
3,513 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page